table of content
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals for Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceuticals for Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceuticals for Therapeutic Overall Market Size
2.1 Global Radiopharmaceuticals for Therapeutic Market Size: 2022 VS 2030
2.2 Global Radiopharmaceuticals for Therapeutic Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radiopharmaceuticals for Therapeutic Players in Global Market
3.2 Top Global Radiopharmaceuticals for Therapeutic Companies Ranked by Revenue
3.3 Global Radiopharmaceuticals for Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Radiopharmaceuticals for Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Radiopharmaceuticals for Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals for Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Radiopharmaceuticals for Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Radiopharmaceuticals for Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Radiopharmaceuticals for Therapeutic Market Size Markets, 2022 & 2030
4.1.2 Radium-223
4.1.3 Lutetium-177
4.1.4 Iodine-131
4.1.5 Other
4.2 By Type - Global Radiopharmaceuticals for Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceuticals for Therapeutic Revenue, 2018-2023
4.2.2 By Type - Global Radiopharmaceuticals for Therapeutic Revenue, 2024-2030
4.2.3 By Type - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radiopharmaceuticals for Therapeutic Market Size, 2022 & 2030
5.1.2 Thyroid
5.1.3 Bone Metastasis
5.1.4 Lymphoma
5.1.5 Other
5.2 By Application - Global Radiopharmaceuticals for Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceuticals for Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global Radiopharmaceuticals for Therapeutic Revenue, 2024-2030
5.2.3 By Application - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Radiopharmaceuticals for Therapeutic Market Size, 2022 & 2030
6.2 By Region - Global Radiopharmaceuticals for Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceuticals for Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global Radiopharmaceuticals for Therapeutic Revenue, 2024-2030
6.2.3 By Region - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.3.2 US Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.3.3 Canada Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.3.4 Mexico Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.4.2 Germany Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.3 France Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.4 U.K. Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.5 Italy Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.6 Russia Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.7 Nordic Countries Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.8 Benelux Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.5.2 China Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5.3 Japan Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5.4 South Korea Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5.5 Southeast Asia Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5.6 India Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.6.2 Brazil Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.6.3 Argentina Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.7.2 Turkey Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.7.3 Israel Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.7.4 Saudi Arabia Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.7.5 UAE Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
7 Radiopharmaceuticals for Therapeutic Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Radiopharmaceuticals for Therapeutic Major Product Offerings
7.1.4 Bayer Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Radiopharmaceuticals for Therapeutic Major Product Offerings
7.2.4 Novartis Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 China Isotope & Radiation
7.3.1 China Isotope & Radiation Company Summary
7.3.2 China Isotope & Radiation Business Overview
7.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Major Product Offerings
7.3.4 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.3.5 China Isotope & Radiation Key News & Latest Developments
7.4 Dongcheng
7.4.1 Dongcheng Company Summary
7.4.2 Dongcheng Business Overview
7.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Major Product Offerings
7.4.4 Dongcheng Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.4.5 Dongcheng Key News & Latest Developments
7.5 Q BioMed
7.5.1 Q BioMed Company Summary
7.5.2 Q BioMed Business Overview
7.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Major Product Offerings
7.5.4 Q BioMed Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.5.5 Q BioMed Key News & Latest Developments
7.6 Curium Pharmaceuticals
7.6.1 Curium Pharmaceuticals Company Summary
7.6.2 Curium Pharmaceuticals Business Overview
7.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Major Product Offerings
7.6.4 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Curium Pharmaceuticals Key News & Latest Developments
7.7 Jubilant DraxImage
7.7.1 Jubilant DraxImage Company Summary
7.7.2 Jubilant DraxImage Business Overview
7.7.3 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Major Product Offerings
7.7.4 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.7.5 Jubilant DraxImage Key News & Latest Developments
7.8 Lantheus
7.8.1 Lantheus Company Summary
7.8.2 Lantheus Business Overview
7.8.3 Lantheus Radiopharmaceuticals for Therapeutic Major Product Offerings
7.8.4 Lantheus Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.8.5 Lantheus Key News & Latest Developments
7.9 Spectrum Pharmaceuticals
7.9.1 Spectrum Pharmaceuticals Company Summary
7.9.2 Spectrum Pharmaceuticals Business Overview
7.9.3 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Major Product Offerings
7.9.4 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.9.5 Spectrum Pharmaceuticals Key News & Latest Developments
7.10 Progenics Pharmaceuticals
7.10.1 Progenics Pharmaceuticals Company Summary
7.10.2 Progenics Pharmaceuticals Business Overview
7.10.3 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Major Product Offerings
7.10.4 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.10.5 Progenics Pharmaceuticals Key News & Latest Developments
7.11 International Isotopes
7.11.1 International Isotopes Company Summary
7.11.2 International Isotopes Business Overview
7.11.3 International Isotopes Radiopharmaceuticals for Therapeutic Major Product Offerings
7.11.4 International Isotopes Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.11.5 International Isotopes Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
